From: Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
MSKCC
Treatment
nal-IRI + 5-FU/LV
Patients
56
toxicities
any grade (%)
grade 3/4 (%)
Nausea
33 (59)
2 (4)
Vomiting
18 (32)
Diarrhea
35 (63)
1 (2)
Fatigue
45 (80)
Anorexia
32 (57)
0 (0)
Neutropenia
16 (29)
Anemia
50 (89)
10 (18)